MehmetF GokhamHepgurMD

PubMed

• 1 citations
  Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.
  Tanya B. Dorff, Cy Wilkins, Mehmet Hepgur, David I. Quinn
  Clinical Genitourinary Cancer. 2014-04-01
• 7 citations
  Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
  Preeti Chaudhary, Mehmet Hepgur, Sarmen Sarkissian, Richard J.H. Smith, Ilene C. Weitz
  Blood Transfusion = Trasfusione Del Sangue. 2014-01-01
• 17 citations
  Tivozanib in the treatment of renal cell carcinoma
  Mehmet Hepgur, Sarmad Sadeghi, Tanya B. Dorff, David I. Quinn
  Biologics. 2013-06-11

Journal Articles

• Evaluation of Skull Thickness and Insertion Torque at the Halo Pin Insertion Areas in the Elderly  
  Ebraheim N, Hepgur M, The Spine Journal
• Solitary Splenic Metastasis from Primary Non Small Cell Carcinoma of the Lung  
  Hepgur M Noor M DePlato A, International Journal of Hematology and Oncology

Abstracts/Posters

• Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC)
  Mehmet Faith Hepgur, Tanya B. Dorff, Jie Cai, Mary Reed, Betty Chan, David I. Quinn;, J Clin Oncol 33, 2015 (suppl 7; abstr 181)
• Identification of biological and inflammatory markers for predicting clinical responses to Sipuleucel-T in mCRPC.
  Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
• Clinical and biological factors for immune response to Sipuleucel-T for metastatic castrate resistant prostate cancer.
  Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
• Ewings Sarcoma in adults: A retrospective review of dose and tolerability of treatment.
  Hepgur M, Hu J., Connective Tissue Society 18th Annual Meeting, 9/2013
• Two Year Update on the Evaluation of Patients, Safety, and Efficacy of Sipuleucel-T in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) at an Aca...
  Kam EH, Chan BM, Hepgur M, Dorff TB, Quinn DI, HOPA Annual Meeting, 3/2013
• Changes in circulating tumor cells (CTC) and markers of inflammation after sipuleucel-T treatment.
  Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., J Clin Oncol 31, 2013 (supp, Genitourinary Cancers Symposium, 2/11/2013
• Early Complete Donor Lymphoid Chimerism With Fludarabine, Melphalan And Low Dose (400CGy) Total Body Irradiation Reduced Intensity Conditioning
  Hepgur M McCarthy P, Biology of Blood and Marrow Transplantation, Orlando
• Atypical Presentation Of Vaginal GvHD With Abdominal Pain Crises
  Hepgur M Battiwalla M mcCarthy P, Biology of Blood and Marrow Transplantation, Orlando
• Join now to see all